IPO

Liberty Defense completed $20M Nasdaq IPO under ticker $DETX, offering MIT-licensed weapons detection technology for venue security applications.

SpaceX secures $20B bridge loan to refinance debt ahead of summer IPO at $1.75T valuation, though 2025 losses nearly hit $5B on $18.5B revenue.

SpaceX secured a $20B bridge loan to refinance debt ahead of a planned summer IPO at $1.75 trillion valuation, despite reporting a $5 billion loss in 2025.

Rosen Law Firm files class action against zSpace Inc. ($ZSPC) for alleged securities fraud involving misstatements about preferred shareholder obligations and litigation risks. June 22, 2026 deadline for lead plaintiff motions.

Agomab Therapeutics raised $208M in February 2026 IPO and reported €116.5M cash, funding operations into H1 2029 while advancing two lead drug candidates.

Kailera Therapeutics surged 63% on Nasdaq debut as weight-loss drug spinoff from Hengrui Pharma, raising $625M and validating the 'NewCo' model for Chinese pharmaceutical companies.

Class action lawsuit filed against Navan alleging its October 2025 IPO prospectus contained false statements about sales and marketing expense requirements.

Three space stocks—Redwire, Spire Global, and Arxis—trade at significant discounts to sector peers while offering exposure to growing commercial space markets.

Class action lawsuit filed against $GEMI alleges false statements on crypto platform viability and overstated expansion plans. Lead plaintiff deadline set for May 18, 2026.

Law Offices investigate Via Transportation for allegedly misrepresenting itself as software platform when operating as transit services contractor, with stock down 59.7% from IPO.

$AVEX slides 12.23% after surging 65%+ in initial post-IPO trading. Stock navigates volatile price discovery phase amid profit-taking.

Law firm investigates $VIA for allegedly misrepresenting itself as software platform while operating transit contractor, with stock down 59.7% from IPO.

Jersey Mike's confidentially filed for IPO after Blackstone's $8B acquisition. Revenue grew 10.6% to $309.8M, but net income fell 23.1%, raising profitability concerns.

Beta Technologies raised $1B+ in IPO but faces $373M annual losses, regulatory uncertainty, and unproven market demand for eVTOL cargo delivery.

Law firm files class action against Gemini Space Station for allegedly overstating crypto platform viability and financial prospects in IPO disclosures.

OpenAI valued at $852B remains private with no IPO timeline. Retail investors can access exposure through Microsoft stake, ARK funds, or secondary markets.

Google secures exclusive geothermal access through Fervo Energy deal with competitor-blocking clauses and right of first refusal, creating 3-gigawatt competitive advantage.

Chinese satellite startup Spacety raises $190M and prepares for IPO as space sector surges, though most competitors remain unprofitable.

Hamilton Global Opportunities posts €5.77M profit, €44.74 NAV per share, and €3.44 dividend after successful MIAX exit.

AI chipmaker Cerebras files for Nasdaq IPO under $CBRS, boasting $510M 2025 revenue and major tech partnerships amid intense competition with $NVDA.